After a rough few years for the multibillion-dollar pharmaceutical company --including recalls, lawsuits and a bruising management shakeup -- Johnson & Johnson regained some momentum last year. The sprawling conglomerate still makes everything from baby powder to artificial hips. But most of J&J's recent growth has been fueled by its pharmaceutical division, which makes the blockbuster drugs Remicade, for Crohn's Disease and rheumatoid arthritis, and Stelara, immunology medication.
Some of America's largest corporations are also great workplaces
.
